ATM: From gene to function

Human Molecular Genetics

Volumn 7, Issue 10, 1998, Pages 1555-1563

  Rotman, Galit ^a   Shiloh, Yosef ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE;

APOPTOSIS; ATAXIA TELANGIECTASIA; CANCER INHIBITION; CARBOXY TERMINAL SEQUENCE; CELL CYCLE; DNA REPAIR; DNA STRAND BREAKAGE; GENE; GENE FUNCTION; GENE MUTATION; HUMAN; PRIORITY JOURNAL; REVIEW; SEQUENCE HOMOLOGY; T LYMPHOCYTE; TUMOR SUPPRESSOR GENE;

ANIMALS; ATAXIA TELANGIECTASIA; CATALYTIC DOMAIN; CELL CYCLE PROTEINS; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; FEMALE; GENES, TUMOR SUPPRESSOR; GENOTYPE; GROWTH DISORDERS; HUMANS; MALE; MEIOSIS; MICE; MICE, KNOCKOUT; MUTATION; NEOPLASMS, EXPERIMENTAL; NERVE DEGENERATION; PHENOTYPE; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; RADIATION TOLERANCE; TUMOR SUPPRESSOR PROTEINS;

ATAXIA; ATAXIA TELANGIECTASIA;

EID: 0031663617     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/7.10.1555     Document Type: Review

References (109)

1. Lavin, M.F. and Shiloh, Y. (1997) The genetic defect in ataxia-telangiectasia. Annu. Rev. Immunol., 15, 177-202.
2. Shiloh, Y. (1997) Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart. Annu. Rev. Genet., 31, 635-662.
3. Gatti, R.A. (1998) Ataxia-telangiectasia. In Vogelstein, B. and Kinzler, K.W. (eds), The Genetic Basis of Human Cancer. McGraw-Hill, New York, pp. 275-300.
4. Morgan, S.E. and Kastan, M. (1997) p53 and ATM: cell cycle, cell death, and cancer. Adv. Cancer Res., 71, 1-25.
5. Westphal, C.H. (1997) Cell cycle signaling: ATM displays its many talents. Curr. Biol., 7, R789-R792.
6. Kaufmann, W.K. and Paules, R.S. (1996) DNA damage and cell cycle checkpoints. FASEB J., 10, 238-247.
7. Khanna, K.K., Beamish, H., Yan, J., Hobson, K., Williams R., Dunn, I. and Lavin, M.F. (1995) Nature of G1/S cell cycle checkpoint defect in ataxia-telangiectasia. Oncogene, 11, 609-618.
8. 1 cell cycle checkpoint pathway and ataxiatelangiectasia. Cancer Res., 54, 5054-5058.
9. Liu, V.F. and Weaver, D.T. (1993) The ionizing radiation-induced replication protein A phosphorylation response differs between ataxia-telangiectasia and normal human cells. Mol. Cell. Biol., 13, 7222-7231.
10. Cheng, X., Cheong, N., Wang, Y. and Iliakis, G. (1996) Ionizing radiation-induced phosphorylation of RPA p34 is deficient in ataxia-telangiectasia and reduced in aged normal fibroblasts. Radiother. Oncol., 39, 43-52.
11. Morgan, S.E. and Kastan, M. (1997) Dissociation of radiation-induced phosphorylation of replication protein A from the S-phase checkpoint. Cancer Res., 57, 3386-3389.
12. 2 checkpoint function in cells from individuals with familial cancer syndromes. Cancer Res., 55, 1763-1773.
13. Beamish, H., Williams, R., Chen, P. and Lavin, M.F. (1996) Defect in multiple cell cycle checkpoints in ataxia-telangiectasia postirradiation. J. Biol. Chem., 271, 20486-20493.
14. Shafman, T.D., Saleem, A., Kyriakis, J., Weichselbaum, R., Kharbanda, S. and Kufe D.W. (1995) Defective induction of stress-activated protein kinase activity in ataxia-telangiectasia cells exposed to ionizing radiation. Cancer Res., 55, 3242-3245.
15. Baskaran, R., Wood, L.D., Whitaker, L.L., Canman, C.E., Morgan, S.E., Xu, Y., Barlow, C., Baltimore, D., Wynshaw-Boris, A., Kastan, M.B. and Wang, J.Y.J. (1997) Ataxia-telangiectasia mutated protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature, 387, 516-519.
16. Shafman, T., Khanna, K.K., Kedar, P., Spring, K., Kozlov, S., Yen, T., Hobson, K., Gatei, M., Zhang, N., Watters, D., Egerton, M., Shiloh, Y., Kharbanda, S., Kufe, D. and Lavin, M.F. (1997) Interaction between ATM protein and c-Abl in response to DNA damage. Nature, 387, 520-523.
17. Shiloh, Y. (1995) Ataxia-telangiectasia: closer to unraveling the mystery. Eur. J. Hum. Genet., 3, 116-138.
18. Luo, C.-M., Tang, W., Mekeel, K.L., DeFrank, J.S., Anné, P.R. and Powell, S.N. (1996) High frequency and error-prone DNA recombination in ataxia telangiectasia cell lines. J. Biol. Chem., 271, 4497-4503.
19. Dar, M.E., Winters, T.A. and Jorgensen, T.J. (1997) Identification of defective illegitimate recombinational repair of oxidatively-induced DNA double-strand breaks in ataxia-telangiectasia cells. Mutat. Res. 384, 169-179.
20. Foray, N., Priestley, A., Alsbeih, G., Badie, C., Capulas, E.P., Arlett, C.F. and Malaise, E.P. (1997) Hypersensitivity of ataxia telangiectasia fibroblasts to ionizing radiation is associated with a repair deficiency of DNA double-strand breaks. Int. J. Radiat. Biol., 72, 271-283.
21. Rotman, G. and Shiloh, Y. (1997) Ataxia-telangiectasia: is ATM a sensor of oxidative damage and stress? BioEssays, 19, 911-917.
22. Jeggo, P.A., Carr, A.M. and Lehmann, A.R. (1998) Splitting the ATM. Trends Genet., in press.
23. Brown, J.M. (1997) Correspondence re: M.Stephen Meyn, ataxia telangiectasia and cellular responses to DNA damage. Cancer Res., 57, 2313-2315.
24. Pandita, T.K., Pathak, S. and Geard, C.R. (1995) Chromosome end associations, telomeres and telomease activity in ataxia telangiectasia cells. Cytogenet. Cell Genet., 71, 86-93.
25. Xia, S.J., Shammas, M.A. and Shmookler Reis, R.J. (1996) Reduced telomere length in ataxia-telangiectasia fibroblasts. Mutat. Res., 364, 1-11.
26. Metcalfe J.A., Parkhill, J., Campbell L., Stacey, M., Biggs, P., Byrd, P.J. and Taylor, A.M.R. (1996) Accelerated telomere shortening in ataxia telangiectasia. Nature Genet., 13, 350-353.
27. Khanna, K.K., Yan, J., Watters, D., Hobson K., Beamish, H., Spring, K., Shiloh, Y., Gatti, R.A. and Lavin, M.F. (1997) Defective signalling through the B cell antigen receptor in ataxia-telangiectasia cells. J. Biol. Chem., 272, 9489-9495.
28. Kondo, N., Inoue, S., Nishimura, S., Kasahara, K., Kameyama, T., Miwa Y., Lorenzo, P.R. and Orii, T. (1993) Defective calcium-dependent signal transduction in T lymphocytes of ataxia-telangiectasia. Scand. J. Immunol., 38, 45-48.
29. Reinhart, P.M., D'Souza, T., Rhodes, N., Foster, C.D., Ziv, Y., Kirsch, D.G., Shiloh, Y., Kastan, M.B. and Gilmer, T.M. (1998) Defective potassium currents in ataxia telangiectasia. Annual Meeting of the Society for Neuroscience, Los Angeles, CA.
30. Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y. Vanagaite, L., Tagle, D.A., Smith, S., Uziel, T., Sfez, S., Ashkenazi, M., Pecker, I., Frydman, M., Harnik, R., Patanjali, S.R., Simmons, A., Clines, G.A., Sartiel, A., Gatti, R.A., Chessa, L., Sanal, O., Lavin, M.F., Jaspers, N.G.J., Taylor, A.M.R., Arlett, C.F., Miki, T., Weissman, S.M., Lovett, M., Collins, F.S. and Shiloh, Y. (1995) A single ataxia-telangiectasia gene with a product similar to PI-3 kinase. Science, 268, 1749-1753.
31. Savitsky, K., Sfez, S., Tagle, D.A., Ziv, Y., Sartiel, A., Collins, F.S., Shiloh, Y. and Rotman, G. (1995) The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum. Mol. Genet., 4, 2025-2032.
32. Savitsky, K., Platzer, M., Uziel, T., Gilad, S., Sartiel, A., Rosenthal, A., Elroy-Stein, O., Shiloh, Y and Rotman, G. (1997) Ataxia-telangiectasia: structural diversity of untranslated sequences suggests complex post-transcriptional regulation of ATM gene expression. Nucleic Acids Res., 25, 1678-1684.
33. Byrd, P.J., Cooper, P.R., Slankovic, T., Kullar, H.S., Watts, G.D., Robinson, P.J. and Taylor, A.M.R. (1996) A gene transcribed from the bidirectional ATM promoter coding for a serine rich protein: amino acid sequence, structure and expression studies. Hum. Mol. Genet., 5, 1785-1791.
34. Imai, T., Yamauchi, M., Seki, N., Sugawara, T., Saito, T., Matsuda, Y., Ito, H., Nagase, T., Nomura, N. and Hori, T. (1996) Identification and characterization of a new gene physically linked to the ATM gene. Genome Res., 6, 439-447.
35. Chen, X., Yang, L., Udar, N., Liang, T., Uhrhammer, N., Xu, S., Bay, J.-O., Wang, X., Dandakar, S., Chiplunkar, S., Klisak, I., Telatar, M., Yang, H., Concannon, P. and Gatti, R.A. (1997) CAND3: A ubiquitously expressed gene immediately adjacent and in opposite transcriptional orientation to the ATM gene at 11q23.1. Mamm. Genome, 8, 129-133.
36. Zhao, J., Dynlacht, B., Imai, T., Hori, T. and Harlow, E. (1998) Expression of NPAT, a novel substrate of cyclin E-CDK2, promotes S-phase entry. Genes Dev., 12, 456-461.
37. Ziv, Y., Bar-Shira, A., Pecker, I., Russell, P., Jorgensen, T.J., Tsarfati, I. and Shiloh, Y. (1997) Recombinant ATM protein complements the cellular A-T phenotype. Oncogene, 15, 159-167.
38. Zhang, N., Chen, P., Khanna, K.K., Scott, S., Gatei, M., Kozlov, S., Watters, D., Spring, K., Yen, T. and Lavin, M.F. (1997) Isolation of full-length ATM cDNA and correction of the ataxia-telangiectasia cellular phenotype. Proc. Natl Acad. Sci. USA, 94, 8021-8026.
39. Zhang, N., Chen, P., Gatei, M., Scott, S., Khanna, K.K. and Lavin, M.F. (1998) An anti-sense construct of full-length ATM cDNA imposes a radiosensitive phenotype on normal cells. Oncogene, in press.
40. Morgan, S.E., Lovly, C., Pandita, T.K., Shiloh, Y and Kastan, M. (1997) Fragments of ATM which have dominant-negative or complementing activity. Mol. Cell. Biol., 17, 2020-2029.
41. Hoekstra, M.F. (1997) Responses to DNA damage and regulation of cell cycle checkpoints by the ATM protein kinase family. Curr. Opin. Genet. Dev., 7, 170-175.
42. Jeggo, P.A. (1997) DNA-PK: at the cross-roads of biochemistry and genetics. Mutat. Res., 384, 1-14.
43. Bentley, N.J., Holtzman, D.A., Flaggs, G., Keegan, K.S., DeMaggio, A., Ford, J.C., Hoekstra, M. and Carr, A.M. (1996) The Schizosaccharomyces pombe rad3 checkpoint gene. EMBO J., 15, 6641-6651.
44. Cimprich, K.A., Shin, T.B., Keith, C.T. and Schreiber, S.L. (1996) cDNA cloning and gene mapping of a candidate human cell cycle checkpoint protein. Proc. Natl Acad. Sci. USA, 93, 2850-2855.
45. Brunn, G.J., Hudson C.C., Sekulic, A., Williams, J.M., Hosoi, H., Houghton, P.J., Lawrence, J.C. and Abraham, R.T. (1997) Phosphorylation of the translational represser PHAS-I by the mammalian target of rapamycin. Science, 277, 99-101.
46. Burnett, P.E., Barrow, R.K., Cohen, N.A., Snyder, S.H. and Sabatini, D.M. (1998) RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. Proc. Natl Acad. Sci. USA, 95, 1432-1437.
47. Thomas, G. and Hall, M.N. (1997) TOR signalling and control of cell growth. Curr. Opin. Cell Biol. 9, 782-787.
48. Keegan, K.S., Holtzman, D.A., Plug, A.W., Christenson, E.R., Brainerd, E.E., Flaggs, G., Bentley, N.J., Taylor, E.M., Meyn, M.S., Moss, S.B., Carr, A.M., Ashley, T. and Hoekstra, M.F. (1996) The Atr and Atm protein kinases associate with different sites along meiotically pairing chromosomes. Genes Dev., 10, 2423-2437.
49. Chen, G. and Lee, E.Y.P. (1996) The product of the ATM gene is a 370-kDa nuclear phosphoprotein. J. Biol. Chem., 271, 33693-33697.
50. Soares, H.D., Morgan, J.I. and McKinnon, P.J. (1998) Atm expression patterns suggest a contribution from the peripheral nervous system to the phenotype of ataxia-telangiectasia. Neuroscience, 86, 1045-1054.
51. Lakin, N.D., Weber, P., Stankovic, T., Rottinghaus, S.T., Taylor, A.M.R. and Jackson, S.P. (1996) Analysis of the ATM protein in wild-type and ataxia-telangiectasia cells. Oncogene, 13, 2707-2716.
52. Brown, K.D., Ziv, Y., Sadanandan, S.N., Chessa, L., Collins. F.S., Shiloh, Y. and Tagle, D.A. (1997) The ataxia-telangiectasia gene product, a constitutively expressed nuclear protein that is not upregulated following genome damage. Proc. Natl Acad. Sci. USA, 94, 1840-1845.
53. Watters, D., Khanna, K.K., Beamish, H., Birrell, G., Spring, K., Kedar, P., Gatei, M., Stenzel, D., Hobson, K., Kozlov, S., Zhang, N., Farell, A., Ramsay, J., Gatti, R. and Lavin, M. (1997) Cellular localisation of the ataxia-telangiectasia (ATM) gene product and discrimination between mutated and normal forms. Oncogene, 14, 1911-1921.
54. Scott, S.P., Zhang, N., Khanna, K.K., Khromykh, A., Hobson K., Watters, D. and Lavin M.F. (1998) Cloning and expression of the ataxia-telangiectasia gene in baculovirus. Biochem. Biophys. Res. Commun., 245, 144-148.
55. Sedgwick, R.P. and Boder, E. (1991) Ataxia-telangiectasia. In Vinken, P.J., Bruyn, G.W. and Klawans, H.L. (eds), Handbook of Clinical Neurology, Vol. 16. Elsevier Scientific Publishers, Amsterdam, pp. 347-423.
56. Barlow, C., Hirotsune, S., Paylor, R., Liyanage, M., Eckhaus, M., Collins, F., Shiloh, Y., Crawley, J.N., Ried, T., Tagle, D. and Wynshaw-Boris, A. (1996) Aim-deficient mice: a paradigm of ataxia-telangiectasia. Cell, 86, 159-171.
57. Xu, Y., Ashley, T., Brainerd, E.E., Bronson, R.T., Meyn, S.M. and Baltimore, D. (1996) Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects and thymic lymphoma. Genes Dev., 10, 2411-2422.
58. Plug, A.W., Peters, A.H.F.M., Xu, Y., Keegan, K.S., Hoekstra, M.F., Baltimore, D., deBoer, P. and Ashley, T. (1997) ATM and RPA in meiotic chromosome synapsis and recombination. Nature Genet., 17, 457-461.
59. Weinert, T. (1997) A DNA damage checkpoint meets the cell cycle engine. Science, 277, 1450-1451.
60. Nurse, P. (1997) Checkpoint pathways come of age. Cell, 91, 865-867.
61. Flaggs, G., Plug, A.W., Dunks, K.M., Mundt, K.E., Ford, J.C., Quiggle, M.R.E., Taylor, E.M., Westphal, C.H., Ashley, T., Hoekstra, M.F. and Carr, A.M. (1997) Aim-dependent interactions of a mammalian Chk1 homolog with meiotic chromosomes. Curr. Biol., 7, 977-986.
62. Barlow, C., Liyanage, M., Moens, P.B., Deng, C.X., Ried, T. and Wynshaw-Boris, A. (1997) Partial rescue of the prophase I defects of Atm-deficient mice by p53 and p21 null alleles. Nature Genet., 17, 462-466.
63. Jung, M., Kondratyev, A., Lee, S., Dimtchev, A. and Dritschilo, A. (1997) ATM gene product phosphorylates IκB-α. Cancer Res., 57, 24-27.
64. Lin, T.-A, Kong, X., Haystead, T.A.J., Pause, A., Belsham, G., Sonenberg, N. and Lawrence, J.C. Jr (1994) PHAS-I as a link between mitogen-activated protein kinase and translation initiation. Science, 266, 653-656.
65. Siliciano, J.D., Canman, C.E., Taya, Y., Sakaguchi, K., Appella, E. and Kastan, M.B. (1997) DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev., 11, 3471-3481.
66. Shieh, S.-Y., Ikeda M., Taya, Y. and Prives, C. (1997) DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell, 91, 325-334.
67. Kharbanda, S., Ren, R., Pandey, P., Shafman, T.D., Feller, S.M., Weichselbaum, R.R. and Kufe, D.W. (1995) Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents. Nature, 376, 785-788.
68. Ivanov, E.L. and Haber, J.E. (1997) DNA repair: RAD alert. Curr. Biol., 7, R492-R495.
69. Lim, D.-S., Kirsch, D.G., Canman, C.E., Ahn, J.-H., Ziv, Y., Newman, L.S., Damell, R.B., Shiloh, Y. and Kastan, M.B. (1998) Atm binds β-adaptin: a novel explanation for pleiotropic abnormalities in ataxia telangiectasia. Proc. Natl Acad. Sci. USA, in press.
70. Concannon, P. and Gatti, R.A. (1997) Diversity of ATM mutations detected in patients with ataxia-telangiectasia. Hum. Mutat., 10, 100-107.
71. Gilad, S., Khosravi, R., Harnik, R., Ziv, Y., Shkedy, D., Galanty, Y. Frydman, M., Levi, J., Sanal, O., Chessa, L., Smeets, D., Shiloh, Y. and Bar-Shira, A. (1998) Identification of ATM mutations using extended RT-PCR and restriction endonuclease fingerprinting, and elucidation of the repertoire of A-T mutations in Israel. Hum. Mutat., 11, 69-75.
72. Stankovic, T., Kidd, A.M.J., Suttcliffe, A., McGuire, G.M., Robinson, P., Weber, P., Bedenham, T., Bradwell, A.R., Easton, D.F., Lennox, G.G., Haites. N., Byrd, P.J. and Taylor, A.M.R. (1998) ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukaemia, lymphoma and breast cancer. Am. J. Hum. Genet., 62, 334-345.
73. Telatar, M., Teraoka, S., Wang, Z., Chun, H.H., Liang, T., Castellvi-Bel, S., Udar, N., Borresen, A.-L., Chessa, L., Bematowska-Matuszkievicz, E., Porras, O., Watanabe, M., Junker, A., Concannon, P. and Gatti, R.A. (1998) Ataxia-telangiectasia: identification and detection of founder-effect mutations in the ATM gene in ethnic populations. Am. J Hum. Genet., 62, 86-97.
74. Gilad, S., Bar-Shira, A., Harnik, R., Shkedy, D., Ziv, Y., Khosravi, R., Brown, K., Vanagaite, L., Xu, G., Frydman, M., Lavin, M.F., Hill, D., Tagle, D.A. and Shiloh, Y. (1996) Ataxia-telangiectasia: founder effect among North African Jews. Hum. Mol. Genet., 5, 2033-2037.
75. Laake, K., Telatar, M., Geitvik, G.A., Hansen, R., Heiberg, A., Andersen, A., Gatti, R.A. and Borresen-Dale, A.-L. (1998) Identical mutation in 55% of the ATM alleles in 11 Norweigian A-T families: evidence for a founder effect. Eur. J. Hum. Genet., in press.
76. Gilad, S., Khosravi, R., Shkedy, D., Uziel, T., Ziv, Y., Savitsky, K., Rotman, G., Smith, S., Chessa, L., Jorgensen, T.J., Harnik, R., Frydman, M., Sanal, O., Portnoi, S., Goldwicz, Z., Jaspers, N.G.J., Gatti, R.A., Lenoir, G., Lavin, M.F., Tatsumi, K., Wegner, R.D., Shiloh, Y and Bar-Shira, A. (1996) Predominance of null mutations in ataxia-telangiectasia. Hum. Mol. Genet., 5, 433-439.
77. McConville, C.M., Stankovic, T., Byrd, P.J., McGuire, G.M., Yao, Q.-Y., Lennox, G.G. and Taylor, A.M.R. (1996) Mutations associated with variant phenotypes in ataxia-telangiectasia. Am. J. Hum. Genet., 59, 320-330.
78. Gilad, S., Chessa, L., Khosravi, R., Russell, P., Galanty, Y., Piane, M., Gatti, R.A., Jorgensen, T.J., Shiloh, Y. and Bar-Shira, A. (1998) Genotype-phenotype relationships in ataxia-telangiectasia (A-T) and A-T variants. Am. J. Hum. Genet., 62, 551-561.
79. Stilgenbauer, S., Schaffner, C., Litters, A., Liebish, P., Gilad, S., Bar-Shira, A., James, M.R., Lichter, P. and Dohner, H. (1997) Biallelic mutations in the ATM gene in T-prolymphocytic leukemia. Nature Med., 10, 1155-1159.
80. Vorechovsky, I., Luo, L., Dyer, M.J.S., Catovsky, D., Amlot, P.L., Yaxley, J., Foroni, L., Hammarstrom, L., Webster, A.D.B. and Yuille, M.A.R. (1997) Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia. Nature Genet., 17, 96-99.
81. Yuille, M.A.R., Coignet, L.J.A., Abraham, S.M., Yaqub, F., Luo, L., Matutes, E., Brito-Babapulle, V., Vorechovsky, I., Dyer, M.J.S. and Catovsky, D. (1998) ATM is usually rearranged in T-cell prolymphocytic leukemia. Oncogene, 16, 789-796.
82. Stoppa-Lyonnet, D., Soulier, J., Lauge, A., Dastot, H., Garand, R., Sigaux, F. and Stern, M.H. (1998) Inactivation of the ATM gene in T-cell prolymphocytic leukemias. Blood, in press.
83. Taylor, A.M.R., Metcalfe, J.A., Thick, J. and Mak, Y.F. (1996) Leukemia and lymphoma in ataxia telangiectasia. Blood, 87, 423-438.
84. Elson, A., Wang, Y., Daugherty, C.J., Morton, C.C., Zhou, F., Campos-Torres, J. and Leder, P. (1996) Pleiotropic defects in ataxia-telangiectasia protein-deficient mice. Proc. Natl Acad. Sci. USA, 93, 13084-13089.
85. Herzog, K.H., Chong, M., Kapsetaki, M., Morgan, J.I. and McKinnon, P.J. (1998) Requirement of Atm in ionizing radiation-induced cell death in the developing central nervous system. Science, 280, 1089-1091.
86. Xu, Y and Baltimore, D. (1996) Dual roles of ATM in the cellular response to radiation and in cell growth control. Genes Dev., 10, 2401-2410.
87. Westphal, C.H., Schmaltz, C., Rowan, S., Elson, A., Fisher, D.E. and Leder P. (1997) Genetic interactions between atm and p53 influence cellular proliferation and irradiation-induced cell cycle checkpoints. Cancer Res., 57, 1664-1667.
88. El-Deiry, W.S., Harper, J.W., O'Connor, P.M., Velculescu, V.E., Canman, C.E., Jackma, J., Pietenpol, J.A., Burrell, M., Hill, D.E., Wang, Y., Wiman, K.G., Mercer, W.E., Kastan, M.B., Kohn, K.W., Elledge, S.J., Kinzler, K.W. and Vogelstein, B. (1994) WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res., 54, 1169-1174.
89. Wang, Y.A., Elson, A. and Leder, P. (1997) Loss of p21 increases sensitivity to ionizing radiation and delays the onset of lymphoma in atm-deficient mice. Proc. Natl Acad. Sci. USA, 94, 14590-14595.
90. Lin, W.-C. and Desiderio, S. (1995) V(D)J recombination and the cell cycle. Immunol. Today, 16, 279-289.
91. Westphal, C.H., Rowan, S., Schmaltz, C., Elson, A., Fisher, D.E. and Leder, P. (1997) atm and p53 cooperate in apoptosis and suppression of tumorigenesis, hut not in resistance to acute radiation toxicity. Nature Genet., 16, 397-401.
92. Jacks, T., Remington, L., Williams, B.O., Schmitt, E.M., Halachmi, S., Bronson, R.T. and Weinberg, R.A. (1994) Tumor spectrum analysis in p53-mutant mice. Curr. Biol., 4, 1-7.
93. Kemp, C.J., Wheldon, T. and Balmain, A. (1994) p53-deficient mice are extremely susceptible to radiation-induced tumorigenesis. Nature Genet., 8, 66-69.
94. Barlow, C., Brown, K.D., Deng, C.X., Tagle, D.A. and Wynshaw-Boris, A. (1997) Atm selectively regulates distinct p53-dependent cell-cycle checkpoint and apoptotic pathways. Nature Genet., 17, 453-456.
95. Clarke, A.R., Purdie, C.A., Harrison, D.J., Morris, R.G., Bird, C.C., Hooper, M.L. and Wyllie, A.H. (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature. 362, 849-852.
96. Lowe, S.W., Schmitt, E.M., Smith, S.W., Osborne, B.A. and Jacks, T. (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature, 362, 847-849.
97. Enokido, YI., Araki, T., Tanaka, K., Aizawa, S. and Hatanaka, H. (1996) Involvement of p53 in DNA strand break-induced apoptotis in postmitotic CNS neurons. Eur. Neurosci., 8, 1812-1821.
98. Xiang, H., Hochman, D.W., Saya, H., Fujiwara, T., Schwartzkroin, P.A. and Morrison, R.S. (1996) Evidence for p53-mediated modulation of neuronal viability. J. Neurosci., 16, 6753-6765.
99. Wood, K.A. and Youle, R.J. (1995) The role of free radicals and p53 in neuron apoptosis in vivo. J. Neurosci., 15, 5851-5857.
100. Kuljis, R.O., Xu, Y., Aguila, M.C. and Baltimore, D. (1997) Degeneration of neurons, synapses, and neuropils and glial activation in a murine Atm knockout model of ataxia-telangiectasia. Proc. Natl Acad. Sci. USA, 94, 12688-12693.
101. Hendrickson, E.A. (1997) Cell-cycle regulation of mammalian DNA double-strand break repair. Am. J. Hum. Genet., 61, 795-800.
102. Brugarolas, J. and Jacks, T. (1997) Double indemnity: p53, BRCA and cancer. Nature Med., 7, 721-722.
103. Zhang, H., Tombline, G. and Weber, B.L. (1998) BRCA1, BRCA2, and DNA damage response: collision or collusion? Cell, 92, 433-436.
104. Connor, F., Bertwistle, D., Mee, P.J., Ross, G.M., Swift, S., Grigorieva, E., Tybulewicz, V.L.J. and Ashworth, A. (1997) Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation. Nature Genet., 17, 423-430.
105. Jhappan, C., Morse, H.C. III, Fleishmann, R.D., Gottesman, M.M. and Merlino, G. (1997) DNA-PKcs: a T-cell tumour suppressor encoded at the mouse scid locus. Nature Genet., 17, 483-486.
106. Bosma, M.J. and Carroll, A.M. (1991) The scid mouse mutant. Annu. Rev. Immunol., 9, 323-350.
107. Kinzler, K.E. and Vogelstein, B. (1997) Gatekeepers and caretakers. Nature, 386, 761-763.
108. Santana, P., Pena, L.A., Haimovitz-Friedman, A., Martin, S., Green, D., McLoughlin, M., Cordon-Cardo, C., Schuchman, E.H., Fukz, Z. and Kolesnick, R. (1996) Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell. 86, 189-199.
109. Novak, R. (1995) Discovery of AT gene sparks biomedical research bonanza. Science, 268, 1700-1701.